ADIPOQ and metabolic dysfunction-associated steatohepatitis: Insulin resistance is a common factor in NASH and T2DM, and the decrease in insulin secretion coupled with improvements in glycemic control (ie, FPG and HbA1c) likely suggests that there was an improvement in insulin resistance, which might have been partly mediated by the reduction in visceral fat mass and increased adiponectin.